| 自体骨移植与骨形成蛋白治疗成人长骨骨折不愈合的系统评价 |
|
摘要点击次数: 7
全文下载次数: 0
投稿时间：2019-06-04 修订日期：2019-07-10
|
|
|
| 期刊信息：《中国骨伤》年，第卷，第期，第-页 |
| DOI： |
| 基金项目: |
|
| 中文摘要:目的: 通过对自体骨移植与骨形成蛋白治疗成人长骨骨折不愈合相关指标进行Meta分析，为成人长骨骨折不愈合治疗提供参考依据。
方法：按照Cochrane系统评价方法，计算机检索PuMed、Embase、Cochrane图书馆、中国知网（CNKI）、万方数据期刊全文数据库及中国生物医学文献数据库(CBM)发表的对于自体骨移植与骨形成蛋白治疗成人长骨骨折不愈合的随机对照试验，检索时间从各数据库建库至2019年3月。由2名研究者按照纳入和排除标准独立进行筛选文献，提取资料，并采用统一修改后的Jadad评价量表对纳入的文献进行质量评价。采用Cochrane协作网提供的RevMan 5.3统计学软件对两种方法的感染发生率、成功愈合率、二次手术率、住院时间及术中失血量进行Meta分析。
结果:共纳入7个随机对照试验研究共652例患者，自体骨移植组有410例，骨形成蛋白组有242例。Meta分析显示：自体骨移植组与骨形成蛋白组在感染发生率[RR=1.32，95%CI (0.90，1.93)，P=0.16] 、成功愈合率[RR=0.95，95%CI(0.84，1.08)，P=0.43] 、二次手术率[RR=1.16，95%CI (0.43，3.12)，P=0.76]及住院时间[MD=0.69，95%CI(-0.38， 1.75)，P=0.21]差异均无统计学意义。自体骨移植组术中失血量明显高于骨形成蛋白组，差异有统计学意义[MD=223.00，95%CI(32.72，413.28)，P=0.02]。
结论：对于成人长骨骨折不愈合的治疗，骨形成蛋白可以获得和自体骨移植一样的骨折愈合率，同时可以明显减少术中失血量。骨形成蛋白可能更适合成人长骨骨折不愈合的治疗。 |
| 【关键词】股骨骨折, 胫骨骨折，长骨骨折, 骨折不愈合，Meta分析 |
| |
| Autologous bone grafting versus bone morphogenetic protein treatment for nonunion of long bone fractures in adults: a systematic review |
|
| ABSTRACT Objective: To systematically evaluate the clinical effects of autologous bone grafting versus bone morphogenetic protein treatment for nonunion of long bone fractures in adults and provide reference for this fracture.
Methods: According to the methods of systematic review of Cochrane, the randomized controlled trials which compared autologous bone grafting with bone morphogenetic protein treatment for nonunion of long bone fractures in adults were searched in PuMed, Embase, Cochrane library, CNKI ,Wangfang data and CBM from the databases were established to March 2019. Information was screened and extracted according to the inclusion and exclusion criteria by two researchers respectively, and the qualities of the included studies were assessed by the modified Jadad quality scale.The rate of infection，successful union，second operation，hospital stays and intraoperative blood loss were compared by RevMan 5.3 software from Cochrane Collaboration for Meta-analysis.
Results: Seven randomized controlled trials with a total of 652 patients were included, 410 in the autologous bone grafting group and 242 in the bone morphogenetic protein group. Meta analysis showed there were no statistically significant differences regarding infection[RR=1.32 ，95%CI (0.90，1.93)，P=0.16]，successful union[RR=0.95，95%CI(0.84，1.08)，P=0.43]，second operation[RR=1.16，95%CI (0.43，3.12)，P=0.76]，hospital stays[MD=0.69 ，95%CI(-0.38，1.75)，P=0.21] between the 2 groups. But compared with the bone morphogenetic protein treatment, autologous bone grafting significantly increased the intraoperative blood loss[MD=223.00 ，95%CI(32.72， 413.28)，P=0.02].
Conclusion: Since bone morphogenetic proteins can attain as the same fracture healing rate as autologous bone grafting and can significantly reduce the intraoperative blood loss, bone morphogenetic proteins may be a better choice for nonunion of long bone fractures in adults. |
| KEY WORDS femur fracture, tibia fracture, long bone fractures, nonunion, meta-analysis |
| |
| 引用本文，请按以下格式著录参考文献： |
|
|
| 查看 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
